• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Brazil-Based Omnichannel Messaging Service Startup Take Blip Raises USD 70 Million in Series B

Share:

June 17, 2022

Take Blip, a business-focused online messaging platform that recently secured US $70 million in a Series B investment led by Warburg Pincus on 7th June 2022. According to CEO Roberto Oliveira, the funding, which brings Take Blip’s total raised to the US $170 million, will be used for product development, mergers and acquisitions, and customer acquisition.

What the founder has to say:

Take-Blip CEO Roberto Oliveira:

“Every company needed a website in the early phases of the internet, 20 years ago, because people began to experience brands online and use Google to search for brands and items. We’re now seeing a significant paradigm shift in the direction of dialogues. People spend time online in social chats with friends and family, which Take Blip attempts to emulate for businesses. Blip’s true value proposition ensures the ability to comprehend client input and enable rapid evolution.

We have over 240,000 users on our platform, with over 50,000 of them registering in 2022. We passed the $100 million mark in annual recurring revenue this quarter. The company was self-funded and paid dividends until 2020. We’re paying close attention to the more considerable IT downturn, fine-tuning our financial estimates, and being very careful with our investments. At the same time, we’re pleased with our numbers and rapid expansion. Accelerating some acquisition negotiations is one item that could be an opportunity.”

Growing need for Omnichannel Messaging Service:

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

In today’s environment, omnichannel marketing is a must, where Take Blip comes in. Businesses can communicate with clients through their preferred channels thanks to the company’s platform. It automates the connection and makes things incredibly efficient, but it also uses AI technology to create individualized discussions. Take Blip assists businesses in achieving better results.

Customers do not all prefer to text businesses. But, according to surveys commissioned by platforms with messaging services to sell, a rising percentage of people do. Avochato, a messaging vendor, reported that nearly two-thirds of respondents (63%) would prefer a company that texted rather than called. Yotpo, an e-commerce marketing firm, says that more than half of buyers desire to receive messages from firms.

Source: VC Bay

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Medical Properties Trust Announces Public Offering of $750.0 Million of Senior Notes Due 2029Medical Properties Trust Announces Public Offering of $750.0 Million of Senior Notes Due 2029
  • Shionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial PipelineShionogi Buys Qpex Biopharma for $140M, Expands Antimicrobial Pipeline
  • Searches for Digital Health Products Surged 343% During UK LockdownSearches for Digital Health Products Surged 343% During UK Lockdown
  • Top 5 RCM Challenges for Healthcare Executives in the COVID-19 Era and BeyondTop 5 RCM Challenges for Healthcare Executives in the COVID-19 Era and Beyond
  • Wearable Sensor Administers Narcan to Prevent Opioid Overdose DeathsWearable Sensor Administers Narcan to Prevent Opioid Overdose Deaths
  • Northwell Health and Nebraska Medicine Deploys Laudio’s AI Workflow SolutionNorthwell Health and Nebraska Medicine Deploys Laudio’s AI Workflow Solution
  • Genemod Raises $4.5M to Expand Central Research Platform for Biopharma CompaniesGenemod Raises $4.5M to Expand Central Research Platform for Biopharma Companies
  • GI Partners and TA Associates to Acquire Allscripts’ stake in Netsmart TechnologiesGI Partners and TA Associates to Acquire Allscripts’ stake in Netsmart Technologies

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications